Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S.
The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering their products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.
The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.
Federal regulators alleged that U.S. Anesthesia Partners—a portfolio company of Welsh, Carson, Anderson & Stowes—engaged in a “roll-up scheme” in Texas that effectively eliminated the competition. The company denies the allegations, but has agreed to undisclosed terms that would see the lawsuit resolved.
Suggesting the move will significantly advance radiology’s specialtywide imperative to “ditch the disk,” Montreal-based Intelerad Medical Systems has announced it is acquiring a longtime competitor in the image-exchange space.
Orthopedic cone-beam CT supplier CurveBeam AI has received the FDA’s breakthrough device designation for software that computes risk of fracture in patients with osteopenia.
If you want to know how radiologists will learn their jobs 10 to 20 years from now, take a look at the ways schoolkids learn their subjects in the 2022-23 school year.
Warning that proposed new cuts in Medicare reimbursement could afflict U.S. healthcare with “severe and permanent damage,” the Radiology Business Management Association has presented CMS with detailed recommendations for stopping such a dire scenario from arising.
Upon receiving a just-the-facts letter from a federal health official, Australia’s most frequent referrers for musculoskeletal imaging significantly curbed their inclination to place these orders over the next 12 months.